Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $30.50 in the prior trading day, Ideaya Biosciences Inc (NASDAQ: IDYA) closed at $30.80, up 0.98%. In other words, the price has increased by $0.98 from its previous closing price. On the day, 0.72 million shares were traded. IDYA stock price reached its highest trading level at $31.21 during the session, while it also had its lowest trading level at $30.3.
Ratios:
Our goal is to gain a better understanding of IDYA by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 17.50 and its Current Ratio is at 17.50. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Mizuho on July 08, 2024, initiated with a Outperform rating and assigned the stock a target price of $50.
On March 08, 2024, BTIG Research started tracking the stock assigning a Buy rating and target price of $55.
On August 08, 2023, SVB Securities started tracking the stock assigning a Outperform rating and target price of $33.SVB Securities initiated its Outperform rating on August 08, 2023, with a $33 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 26 ’24 when Jason Throne bought 75,000 shares for $40.22 per share.
WHITE MICHAEL ANTHONY sold 28,500 shares of IDYA for $1,032,884 on May 29 ’24. The Chief Scientific Officer now owns 0 shares after completing the transaction at $36.24 per share. On May 15 ’24, another insider, Hata Yujiro S, who serves as the President and CEO of the company, sold 83,856 shares for $42.90 each. As a result, the insider received 3,597,756 and left with 677,887 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IDYA now has a Market Capitalization of 2602030336 and an Enterprise Value of 1902241024. For the stock, the TTM Price-to-Sale (P/S) ratio is 217.56 while its Price-to-Book (P/B) ratio in mrq is 2.52. Its current Enterprise Value per Revenue stands at 159.037 whereas that against EBITDA is -10.071.
Stock Price History:
Over the past 52 weeks, IDYA has reached a high of $47.74, while it has fallen to a 52-week low of $23.41. The 50-Day Moving Average of the stock is -19.27%, while the 200-Day Moving Average is calculated to be -22.63%.
Shares Statistics:
The stock has traded on average 892.96K shares per day over the past 3-months and 1154310 shares per day over the last 10 days, according to various share statistics. A total of 84.48M shares are outstanding, with a floating share count of 76.56M. Insiders hold about 9.37% of the company’s shares, while institutions hold 91.72% stake in the company. Shares short for IDYA as of 1726185600 were 11703657 with a Short Ratio of 13.11, compared to 1723680000 on 11542165. Therefore, it implies a Short% of Shares Outstanding of 11703657 and a Short% of Float of 15.479999999999999.
